800 related articles for article (PubMed ID: 19405003)
61. Update on the medical treatment of juvenile idiopathic arthritis.
Hashkes PJ; Laxer RM
Curr Rheumatol Rep; 2006 Dec; 8(6):450-8. PubMed ID: 17092444
[TBL] [Abstract][Full Text] [Related]
62. Development and testing of reduced joint counts in juvenile idiopathic arthritis.
Bazso A; Consolaro A; Ruperto N; Pistorio A; Viola S; Magni-Manzoni S; Malattia C; Buoncompagni A; Loy A; Martini A; Ravelli A;
J Rheumatol; 2009 Jan; 36(1):183-90. PubMed ID: 19208532
[TBL] [Abstract][Full Text] [Related]
63. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.
Bentley MJ; Greenberg JD; Reed GW
J Rheumatol; 2010 Aug; 37(8):1607-14. PubMed ID: 20595282
[TBL] [Abstract][Full Text] [Related]
64. A selective COX-2 inhibitor, meloxicam, as a treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxen.
Foeldvari I
Clin Exp Rheumatol; 2002; 20(6):874. PubMed ID: 12508788
[No Abstract] [Full Text] [Related]
65. Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
Klotsche J; Minden K; Thon A; Ganser G; Urban A; Horneff G
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):253-62. PubMed ID: 23983081
[TBL] [Abstract][Full Text] [Related]
66. Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
Tarkiainen M; Tynjälä P; Vähäsalo P; Kröger L; Aalto K; Lahdenne P
Pediatr Rheumatol Online J; 2019 Dec; 17(1):80. PubMed ID: 31842940
[TBL] [Abstract][Full Text] [Related]
67. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
68. Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis.
Meiorin S; Filocamo G; Pistorio A; Magni-Manzoni S; Sztajnbok F; Cespedes-Cruz A; Magnani A; Ruperto N; Martini A; Ravelli A
Clin Exp Rheumatol; 2009; 27(3):527-33. PubMed ID: 19604450
[TBL] [Abstract][Full Text] [Related]
69. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score.
Consolaro A; Negro G; Chiara Gallo M; Bracciolini G; Ferrari C; Schiappapietra B; Pistorio A; Bovis F; Ruperto N; Martini A; Ravelli A
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1703-9. PubMed ID: 24980508
[TBL] [Abstract][Full Text] [Related]
70. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.
Oen K; Duffy CM; Tse SM; Ramsey S; Ellsworth J; Chédeville G; Chetaille AL; Saint-Cyr C; Cabral DA; Spiegel LR; Schneider R; Lang B; Huber AM; Dancey P; Silverman E; Rosenberg AM; Cameron B; Johnson N; Dorval J; Scuccimarri R; Campillo S; Petty RE; Duffy KN; Boire G; Haddad E; Houghton K; Laxer R; Turvey SE; Miettunen P; Gross K; Guzman J; Benseler S; Feldman BM; Espinosa V; Yeung RS; Tucker L
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):527-36. PubMed ID: 20391508
[TBL] [Abstract][Full Text] [Related]
71. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
[TBL] [Abstract][Full Text] [Related]
72. Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
Alexeeva EI; Namazova-Baranova LS; Bzarova TM; Valieva SI; Denisova RV; Sleptsova TV; Isaeva KB; Chomahidze AM; Taibulatov NI; Fetisova AN; Karaseva AV; Baranov AA
Pediatr Rheumatol Online J; 2017 Jun; 15(1):51. PubMed ID: 28615036
[TBL] [Abstract][Full Text] [Related]
73. Later-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group?
Greenwald AG; Zakerzadeh A; Laxer RM; Schneider R; Cameron B; Feldman B; Spiegel L; Tse SM; Silverman ED
Clin Exp Rheumatol; 2013; 31(4):645-52. PubMed ID: 23622111
[TBL] [Abstract][Full Text] [Related]
74. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
75. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis.
Vojinovic J; Damjanov N; D'Urzo C; Furlan A; Susic G; Pasic S; Iagaru N; Stefan M; Dinarello CA
Arthritis Rheum; 2011 May; 63(5):1452-8. PubMed ID: 21538322
[TBL] [Abstract][Full Text] [Related]
76. The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Demirkaya E; Ozen S; Sozeri B; Ayaz NA; Kasapcopur O; Unsal E; Makay BB; Barut K; Fidanci BE; Simsek D; Cakan M; Consolaro A; Bovis F; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):395-402. PubMed ID: 29637329
[TBL] [Abstract][Full Text] [Related]
77. The Romanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Lazăr C; Iagăru N; Ailioaie C; Ailioaie LM; Laday M; Apostol A; Spîrchez M; Badiu Tișa I; Consolaro A; Bovis F; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):331-338. PubMed ID: 29637333
[TBL] [Abstract][Full Text] [Related]
78. Optimisation of disease assessments in juvenile idiopathic arthritis.
Consolaro A; Schiappapietra B; Dalprà S; Calandra S; Martini A; Ravelli A
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-126-30. PubMed ID: 25365101
[TBL] [Abstract][Full Text] [Related]
79. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).
Salaffi F; Cimmino MA; Leardini G; Gasparini S; Grassi W
Clin Exp Rheumatol; 2009; 27(4):552-9. PubMed ID: 19772784
[TBL] [Abstract][Full Text] [Related]
80. The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Consolaro A; Bovis F; Pistorio A; Cimaz R; De Benedetti F; Miniaci A; Corona F; Gerloni V; Martino S; Pastore S; Barone P; Pieropan S; Cortis E; Podda RA; Gallizzi R; Civino A; Torre F; Rigante D; Consolini R; Maggio MC; Magni-Manzoni S; Perfetti F; Filocamo G; Toppino C; Licciardi F; Garrone M; Scala S; Patrone E; Tonelli M; Tani D; Ravelli A; Martini A; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):251-258. PubMed ID: 29637324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
